News
-
Jet-heeled GeoSpock joins Vodafone backed tech venture
GeoSpock, the Cambridge UK company reinventing how extreme data is analysed, has joined Tomorrow Street – the award-winning Luxembourg-based... Read More
-
University mourns death of Cambridge dontrepreneur Chris Abell
Noted Cambridge dontrepreneur Professor Chris Abell, who co-founded global life science company Astex among other corporate gamechangers, has died at... Read More
-
Elstree Studios expansion to create 800 new jobs
Plans to expand the Hollywood of Hertfordshire – Elstree Studios – have been bolstered by a multimillion pound investment. Known as the birthplace... Read More
-
Galaxy of stars shines via novel auction for East Anglia’s Children’s Hospices
A galaxy of showbiz stars led by serial charity campaigner Griff Rhys Jones are donating novel items to an online auction to raise money for East... Read More
-
Cambridge agri startup lassoes £1.4m from Texas and Oregon ranchers
Cambridge-based AgriTech startup Herdsy has entered the US market with two deals set to be worth £1.4 million in the next five years. The business... Read More
-
CellCentric raises $33m to broaden cancer trials
Cambridge biotech innovator CellCentric has won $33 million of new funding to accelerate cancer trials leveraging its novel drug CCS1477. Hong... Read More
-
Liver-on-Chip pioneer CN Bio launches new toxicity testing
Cambridge Science Park 3D cell culture business CN Bio has enhanced its reputation for innovation with the commercial launch of new drug metabolism... Read More
-
Psyomics clinches £1.5m to transform mental health diagnosis in UK
Cambridge University spin-out Psyomics, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment... Read More
-
Fields of gold as East of England’s farmland market remains resilient
Despite an uncertain economic and political backdrop farmland values in the East of England have remained strong, highlighting underlying confidence... Read More
-
Cambridge Network and Business Weekly push Cluster’s global credentials
Cambridge Network and Business Weekly have strengthened an alliance designed to heighten profile and hopefully win fresh business for local companies... Read More
-
Howes Percival expands after boosting turnover by 23 per cent
Howes Percival has expanded its highly rated employment law team in response to an increase in instructions over the last year. The... Read More
-
Eagle swoops on $9m scale-up funding
Cambridge-based Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in... Read More
-
Hauser seeks €100bn EU cash to fight US and China bid for tech dominance
Cambridge entrepreneur and VC Dr Hermann Hauser is mobilising forces in the EU to create a €100 billion fighting fund to protect European life... Read More
-
Johnson joins Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult in Stevenage has appointed Dr Nick Johnson as its Chief Strategy and Impact Officer. Dr Johnson will focus on the... Read More
-
Friend jets in as Guardtech accelerates growth
Guardtech Cleanrooms in Haverhill has continued its expansion drive with the appointment of Daisy Friend as Business Development Manager. Friend... Read More
-
Cambridge drives FinTech and digital intel deeper into crucial territories
Cambridge is spearheading a pioneering move to accelerate technology enabled financial innovation and knowledge sharing in huge and previously... Read More
-
AstraZeneca coronavirus trials resumed globally as FDA confirms safety
Clinical trials for the AstraZeneca-Oxford University coronavirus vaccine AZD1222 have today have been approved as safe to continue in the US by The... Read More
-
Abcam raises $180m through US IPO
Cambridge-based Abcam, which supplies tools globally for life science research, has had a blockbusting response to its IPO on America’s NASDAQ... Read More
-
Fusion of maths and biology for coding human cells takes giant stride
bit.bio, a Cambridge biomedical startup backed by Silicon Valley investors, has partnered with the London Institute for Mathematical Sciences,... Read More
-
Major cancer treatment advance by STORM Therapeutics
STORM Therapeutics, a Cambridge biotech business focused on the discovery and development of small molecule therapies modulating RNA epigenetics, has... Read More